EyeCon 2026 Banner

News
Media
Conferences
Blog
Publications
Partners
Resources
Subscribe
CE

Navneet Puri, PhD

Articles by Navneet Puri, PhD

Pipeline: Presbyopia, night vision disturbance up next for Vyluma

ByNavneet Puri, PhD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

July 24th 2021

First Vyluma product tackles pediatric myopia

ByNavneet Puri, PhD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

July 23rd 2021

Vyluma pipeline focuses on refractive error

ByNavneet Puri, PhD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

July 22nd 2021

Nevakar spins off ophthalmic-only company Vyluma

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Navneet Puri, PhD,Brooke Henson, Editor

June 1st 2021

A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.

Latest Updated Articles

Pipeline: Presbyopia, night vision disturbance up next for Vyluma
July 24th 2021
First Vyluma product tackles pediatric myopia
July 23rd 2021
Nevakar spins off ophthalmic-only company Vyluma
June 1st 2021
$Vyluma pipeline focuses on refractive error$
Vyluma pipeline focuses on refractive error
July 22nd 2021

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

AOA 2026: Why some patients with dry eye feel pain and others do not

Myopia as a lifelong vision health condition: Long-term ocular risks and modern management strategies

FDA approves Lumvoa (veligrotug-vvze) for active and chronic thyroid eye disease

AOA 2026: High rates of burnout, higher rates of job satisfaction

AOA 2026: Burnout in optometry on par with health care industry trends